EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Australia

Prince of Wales Hospital, Randwick, New South Wales

Royal Brisbane and Women's Hospital, Herston, Queensland

Monash Health, Clayton, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Canada

Princess Margaret Hospital, Toronto, Ontario